Skip to main content
SpringerLink
Log in

Die Vielgestaltigkeit der Virushepatitis

  • Conference paper
90. Kongreß

Part of the book series: Verhandlungen der Deutschen Gesellschaft für Innere Medizin ((VDGINNERE,volume 90))

  • 30 Accesses

Zusammenfassung

Bei der gemeinsamen Planung war von Anfang an klar, daß nur einige Fragen und Themen aufgegriffen werden konnten, die uns auch für den praktisch tätigen Internisten von besonderer Wichtigkeit erschienen. Aber es sollten auch Probleme aufgegriffen werden, die von grundsätzlicher Bedeutung zum Verständnis neuerer Entwicklungen sind.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Albin C, Robinson WS (1980) Protein kinase activity in hepatitis B virus. J Virol 34: 297–302

    PubMed  CAS  Google Scholar 

  2. Almeida JD, Rubenstein D, Stott EJ (1971) New antigen antibody system in Australia antigen positive hepatitis. Lancet 2: 1225–1227

    PubMed  CAS  Google Scholar 

  3. Beasley RP, Hwang LY, Lin CC, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 2: 1129–1132

    PubMed  CAS  Google Scholar 

  4. Berninger M, Hammer M, Hoyer B, Gerin JL (1982) An assay for the detection of the DNA genome of hepatitis B virus in serum. J Med Virol 9: 57–68

    PubMed  CAS  Google Scholar 

  5. Blum HE, Geballe AP, Stowring L, Figus A, Haase AT, Vyas GN (1984) Hepatitis B virus DNA in nonhepatocytes: Demonstration of viral DNA in spleen, bile duct epithelium and vascular elements by in situ hybridization. In: Vyas GN, Dienstag JL, Hoofnagle JH (eds) Viral hepatitis. Grune & Stratton, New York (in press)

    Google Scholar 

  6. Blum HE, Haase AT, Harris JD, Walker D, Vyas GN (1983a) Asymmetric replication of hepatitis B virus DNA in human liver: Demonstration of cytoplasmic minus-strand DNA by Southern blot analyses and in situ hybridization. (Abstr.) Hepatology 3: 840

    Google Scholar 

  7. Blum HE, Stowring L, Figus A, Montgomery CK, Haase AT, Vyas GN (1983b) Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium and vascular elements by in situ hybridization. Proc Natl Acad Sci USA 80: 6685–6688

    PubMed  CAS  Google Scholar 

  8. Bonino F, Hoyer B, Nelson J, Engle R, Verme G, Gerin JL (1981) Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology 1: 386–391

    PubMed  CAS  Google Scholar 

  9. Brechot C, Hadchouel M, Scotto J, Degos F, Charnay P, Trepo C, Tiollais P (1981a) Detection of hepatitis B virus DNA in liver and serum: a direct appraisal of the chronic carrier state. Lancet 2: 765–768

    PubMed  CAS  Google Scholar 

  10. Brechot C, Hadchouel M, Scotto J, Fonck M, Potet F, Vyas GN, Tiollais P (1981b) State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. Proc Natl Acad Sci USA 78: 3906–3910

    PubMed  CAS  Google Scholar 

  11. Brechot C, Nalpas B, Courouce A-M, Duhamel G, Callard P, Carnot F, Tiollais P, Berthelot P (1982) Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. N Engl J Med 306: 1384–1387

    PubMed  CAS  Google Scholar 

  12. Brechot C, Pourcel C, Louise A, Rain B, Tiollais P (1980) Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286: 533–535

    PubMed  CAS  Google Scholar 

  13. Burrell CJ, MacKay P, Greenaway PJ, Hofschneider PH, Murray K (1979) Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature 279: 43–47

    PubMed  CAS  Google Scholar 

  14. Charnay P, Gervais M, Louise A, Galibert F, Tiollais P (1980) Biosynthesis of hepatitis B surface antigen in Escherichia coli. Nature 286: 893–895

    PubMed  CAS  Google Scholar 

  15. Charnay P, Mandart E, Hampe A, Fitoussi F, Tiollais P, Galibert F (1979) Localization of the viral genome and nucleotide sequence of the gene coding for the major polypeptide of the hepatitis B surface antigen ( HBsAg ). Nucleic Acids Res 7: 335–346

    Google Scholar 

  16. Chen D-S, Hoyer BH, Nelson J, Purcell RH, Gerin JL (1982) Detection and properties of hepatitis B viral DNA in liver tissues from patients with hepatocellular carcinoma. Hepatology 2: 42S - 46S

    Google Scholar 

  17. Christman JK, Gerber M, Price PM, Flordellis C, Edelman J, Acs G (1982) Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA. Proc Natl Acad Sci USA 79: 1815–1819

    PubMed  CAS  Google Scholar 

  18. Colbere-Garapin F, Horodniceanu F, Kourilsky P, Garapin AC (1983) Late transient expression of human hepatitis B virus genes in monkey cells. EMBO J 2: 21–25

    PubMed  CAS  Google Scholar 

  19. Crowley C, Liu CC, Levinson AD (1983) Plasmid-directed synthesis of hepatitis B surface antigen in monkey cells. Mol Cell Biol 3: 44–55

    PubMed  CAS  Google Scholar 

  20. Dane DS, Cameron CH, Briggs M (1970) Virus-like particles in serum of patients with Australia antigen associated hepatitis. Lancet 2: 695–698

    Google Scholar 

  21. Delius H, Gough NM, Cameron CH, Murray K (1983) Structure of the hepatitis B virus genome. J Virol 47: 337–343

    PubMed  CAS  Google Scholar 

  22. Dejean A, Brechot C, Tiollais P, Wain-Hobson S (1983) Characterization of integrated hepatitis B viral DNA cloned from a human hepatoma and the hepatoma cell line PCL/PRF/5. Proc Natl Acad Sci USA 80: 2505–2509

    PubMed  CAS  Google Scholar 

  23. Dejean A, Lugassy C, Zafrani S, Tiollais P, Brechot C (1984) Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus. J Gen Virol 65: 651–655

    PubMed  Google Scholar 

  24. Dubois MF, Pourcel C, Rousset S, Charnay P, Tiollais P (1980) Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA. Proc Natl Acad Sci USA 77: 4549–4553

    PubMed  CAS  Google Scholar 

  25. Edman JC, Hallewell RA, Valenzuela P, Goodman HM, Rutter WJ (1981) Synthesis of hepatitis B surface and core antigens in E. coli. Nature 291: 503–506

    CAS  Google Scholar 

  26. Elfassi E, Romet-Lemonne J-L, Essex M, Frances-McLane M, Haseltine WA (1984) Evidence of extrachromosomal forms of hepatitis B viral DNA in a bone marrow culture obtained from a patient recently infected with hepatitis B virus. Proc Natl Acad Sci USA (in press)

    Google Scholar 

  27. Figus A, Blum HE, Vyas GN, De Vergilis S, Cao A, Lippi M, Lai E, Balestrieri A (1984) Hepatitis B viral nucleotide sequences in non-A, non-B or hepatitis B virus-related chronic liver disease. Hepatology (in press)

    Google Scholar 

  28. Fowler MJF, Monjardino J, Tsiquaye KN, Zuckerman AJ, Thomas HC (1984) The mechanism of replication of hepatitis B virus: Evidence of asymmetric replication of the two DNA strands. J Med Virol 13: 83–91

    Google Scholar 

  29. Galibert F, Chen TN, Mandart E (1982) Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J Virol 41: 51–65

    PubMed  CAS  Google Scholar 

  30. Galibert F, Mandart E, Fitoussi F, Tiollais P, Charnay P (1979) Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281: 646–650

    CAS  Google Scholar 

  31. Gerlich W, Robinson WS (1980) Hepatitis B virus contains protein attached to the 5’ terminus of its complete strand. Cell 21: 801–809

    PubMed  CAS  Google Scholar 

  32. Gough N, Murray K (1982) Expression of the hepatitis B virus surface, core and e antigen genes by stable rat and mouse cell lines. J Mol Biol 162: 43–67

    PubMed  CAS  Google Scholar 

  33. Hardy K, Stahl S, Kuepper H (1981) Production in B. Subtilis of hepatitis B core antigen and of major antigen in foot and mouth disease. Nature 293: 481–483

    Google Scholar 

  34. Hirschman SZ, Price P, Garfinkel E, Christman J, Acs G (1980) Expression of cloned hepatitis B virus DNA in human cell cultures. Proc Natl Acad Sci USA 77: 5507–5511

    PubMed  CAS  Google Scholar 

  35. Hruska JF, Clayton DA, Rubenstein JLR, Robinson WS (1977) Structure of hepatitis B Dane particle DNA before and after the Dane particle polymerase reaction. J Virol 21: 666–672

    PubMed  CAS  Google Scholar 

  36. Kaplan PM, Greenman RL, Gerin JL, Purcell RH, Robinson WS (1973) DNA polymerase associated with human hepatitis B antigen. J Virol 12: 995–1005

    PubMed  CAS  Google Scholar 

  37. Kew MC (1984) The possible etiologic role of hepatitis B virus in hepatocellular carcinoma: Evidence from Southern Africa. In: Chisari FV (ed) Advances in hepatitis research. Masson Publ. USA, New York, pp 203–215

    Google Scholar 

  38. Koike K, Kobayashi M, Yaginuma K, Taira M, Takahashi T, Goto Y (1982) Surface antigen gene of hepatitis B virus (subtype adr) cloned in E. coli. Proc Jpn Acad 58: 140–144

    CAS  Google Scholar 

  39. Koshy R, Koch S, Freytag von Loringhoven A, Kahmann R, Murray K, Hofschneider PH (1983) Integration of hepatitis B virus DNA: Evidence for integration in the single-stranded gap. Cell 34: 215–223

    Google Scholar 

  40. Koshy R, Maupas P, Mueller R, Hofschneider PH (1981) Detection of hepatitis B virus-specific DNA in the genomes of human hepatocellular carcinoma and liver cirrhosis tissues. J Gen Virol 57: 95–102

    PubMed  CAS  Google Scholar 

  41. Landers TA, Greenberg HB, Robinson WS (1977) Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. J Virol 23: 368–376

    PubMed  CAS  Google Scholar 

  42. Lieberman HM, LaBreque DR, Kew MC, Hadziyannis SJ, Shafritz DA (1983) Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test; comparison to HBeAg/anti-HBe status in HBeAg carriers. Hepatology 3: 285–291

    PubMed  CAS  Google Scholar 

  43. Lie-Injo LE, Balasegaram M, Lopez CG, Herrera AR (1983) Hepatitis B virus DNA in liver and white blood cells of patients with hepatoma. DNA 2: 299–301

    Google Scholar 

  44. MacKay P, Lees J, Murray K (1981a) The conversion of hepatitis B core antigen synthesized in E. coli into e antigen. J Med Virol 8: 237–243

    CAS  Google Scholar 

  45. MacKay P, Pasek M, Magazin M, Kovacic TR, Allet B, Stahl S, Gilbert W, Schaller H, Bruce SA, Murray K (1981b) Production of immunologically active surface antigens of hepatitis B virus by Escherichia coli. Proc Natl Acad Sci USA 78: 4510–4514

    PubMed  CAS  Google Scholar 

  46. Mandart E, Kay A, Galibert F (1984) Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences. J Virol 49: 782–792

    PubMed  CAS  Google Scholar 

  47. Marion PL, Oshiro LS, Regnery DC, Scullard GA, Robinson WS (1980) A virus in Beechey ground squirrel that is related to hepatitis B virus of humans. Proc Natl Acad Sci USA 77: 2941–2945

    PubMed  CAS  Google Scholar 

  48. McCollum RW, Zuckerman AJ (1981) Viral hepatitis: Report on a WHO informal consultation. J Med Virol 8: 1–29

    Google Scholar 

  49. Mason WS, Aldrich C, Summers J, Taylor JM (1982) Asymmetric replication of duck hepatitis B virus DNA: Free minus-strand DNA. Proc Natl Acad Sci USA 79: 3997–4001

    Google Scholar 

  50. Mason WS, Seal G, Summers J (1980) Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol 36: 829–836

    PubMed  CAS  Google Scholar 

  51. Miyanohara A, To-E A, Nozaki Z, Hamada F, Ohtomo N, Matsubara K (1983) Expression of hepatitis B surface antigen gene in yeast. Proc Natl Acad Sci USA 80: 1–5

    CAS  Google Scholar 

  52. Monjardino J, Fowler MJF, Montano L, Weller I, Tsiquaye KN, Zuckerman Ai, Jones DM, Thomas HC (1982) Analysis of hepatitis virus DNA in the liver and serum of HBe antigen positive chimpanzee carriers. J Med Virol 9: 189–199

    PubMed  CAS  Google Scholar 

  53. Moriarty AM, Hoyer BH, Shih JWK, Gerin JL, Hamer DH (1981) Expression of the hepatitis B surface antigen gene in cell culture by using a simian virus 40 vector. Proc Natl Acad Sci USA 78: 2606–2610

    PubMed  CAS  Google Scholar 

  54. Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K (1983) The complete nucleotide sequence of the cloned hepatitis B virus DNA; subtypes adr and adw. Nucleic Acids Res 11: 1747–1757

    PubMed  CAS  Google Scholar 

  55. Pasek M, Goto T, Gilbert W, Zink B, Schaller H, MacKay P, Leadbetter G, Murray K (1979) Hepatitis B virus genes and their expression in E. coli. Nature 282: 575–579

    CAS  Google Scholar 

  56. Pontisso P, Poon MC, Tiollais P, Brechot C (1984) Detection of hepatitis B virus DNA in human blood mononuclear cells. Br Med J (in press)

    Google Scholar 

  57. Popper H, Gerber MA, Thung SN (1982) The relation of hepatocellular carcinoma to infection with hepatitis B and related viruses in man and animals. Hepatology 2: 1S - 9S

    Google Scholar 

  58. Pourcel C, Sobzack E, Dubois MF, Gervais M, Drouet J, Tiollais P (1982) Antigenicity and immunogenicity of hepatitis B virus particles produced by mouse cells transformed with cloned viral DNA. Virology 121: 175–183

    PubMed  CAS  Google Scholar 

  59. Robinson WS (1977) The genome of hepatitis B virus. Ann Rev Microbiol 31: 357–377

    CAS  Google Scholar 

  60. Robinson WS, Clayton DA, Greenman RL (1974) DNA of a human hepatitis B virus candidate. J Virol 14: 384–391

    PubMed  CAS  Google Scholar 

  61. Robinson WS, Greenman RL (1974) DNA polymerase in the core of the human hepatitis B virus candidate. J Virol 13: 1231–1236

    PubMed  CAS  Google Scholar 

  62. Romet-Lemonne J-L, McLane MF, Elfassi E, Haseltine WA, Azocar J, Essex M (1983) Hepatitis B virus infection in cultured human lymphoblastoid cells. Science 221: 667–669

    PubMed  CAS  Google Scholar 

  63. Sattler F, Robinson WS (1979) Hepatitis B viral DNA molecules have cohesive ends. J Virol 32: 226–233

    PubMed  CAS  Google Scholar 

  64. Scotto J, Hadchouel M, Hery C, Yvart J, Tiollais P, Brechot C (1983) Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: Comparison with results for other viral markers. Hepatology 3: 279–294

    Google Scholar 

  65. Shafritz DA, Kew MC (1981) Identification of integrated hepatitis B virus DNA in human hepatocellular carcinomas. Hepatology 1: 1–8

    PubMed  CAS  Google Scholar 

  66. Shafritz DA, Lieberman HM (1984) The molecular biology of hepatitis B virus. Annu Rev Med 35: 219–232

    PubMed  CAS  Google Scholar 

  67. Shafritz DA, Lieberman HM, Isselbacher KJ, Wands JR (1982) Monoclonal radioimmunoassays for hepatitis B surface antigen: Demonstration of hepatitis B virus DNA or related sequences in serum and viral epitopes in immuno complexes. Proc Natl Acad Sci USA 79: 5675–5679

    Google Scholar 

  68. Shafritz DA, Shouval D, Sherman HI, Hadzyannis SI, Kew MC (1981) Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N Engl J Med 306: 1067–1073

    Google Scholar 

  69. Siddiqui A (1983a) Hepatitis B virus DNA in Kaposi sarcoma. Proc Natl Acad Sci USA 80: 4861–4864

    PubMed  CAS  Google Scholar 

  70. Siddiqui A (1983b) Expression of hepatitis B surface antigen gene in cultured cells by using recombinant plasmid vectors. Mol Cell Biol 3: 143–146

    PubMed  CAS  Google Scholar 

  71. Siddiqui A, Sattler F, Robinson WS (1979) Restriction endonuclease cleavage map and location of unique features of the DNA of hepatitis B virus, subtype adw2. Proc Natl Acad Sci USA 76: 4664–4668

    PubMed  CAS  Google Scholar 

  72. Smith GL, Mackett M, Moss B (1983) Infectious vaccinia virus recombinants that express hepatitis B surface antigen. Nature 302: 490–495

    PubMed  CAS  Google Scholar 

  73. Stahl S, MacKay P, Magazin M, Bruce SA, Murray K (1982) Hepatitis B virus core antigen: Synthesis in Escherichia coli and application in diagnosis. Proc Natl Acad Sci USA 79: 1606–1610

    Google Scholar 

  74. Stenlund A, Lamy D, Lopez-Moreno J, Ahola H, Pettersson U, Tiollais P (1983) Secretion of the hepatitis B virus surface antigen from mouse cells using an extra-chromosomal eucaryotic vector. EMBO J 2: 669–673

    PubMed  CAS  Google Scholar 

  75. Summers J, Mason WS (1982) Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29: 403–415

    PubMed  CAS  Google Scholar 

  76. Summers J, O’Connell A, Millman I (1975) Genome of hepatitis B virus: Restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc Natl Acad Sci USA 72: 4597–4601

    Google Scholar 

  77. Summers J, Smolec J, Snyder R (1978) A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 75: 4533–4537

    PubMed  CAS  Google Scholar 

  78. Szmuness W (1978) Hepatocellular carcinoma and hepatitis B virus: Evidence for a causal relationship. Prog Med Virol 24: 40–69

    PubMed  CAS  Google Scholar 

  79. Szmuness W, Alter HJ, Maynard HE (1982) Viral hepatitis. Franklin Institute Press, Philadelphia

    Google Scholar 

  80. Takahashi K, Akahana Y, Gotanda T, Mishiro T, Imai M, Miyakawa Y, Mayumi M (1979) Demonstration of hepatitis B e antigen in the core of Dane particles. J Immunol 122: 275–279

    PubMed  CAS  Google Scholar 

  81. Tiollais P, Charnay P, Vyas GN (1981) Biology of hepatitis B virus. Science 213: 406–411

    PubMed  CAS  Google Scholar 

  82. Tiollais P, Wain-Hobson S (1984) Molecular genetics of the hepatitis B virus. In: Chisari FV (ed) Advances in Hepatitis Research. Masson Publ., USA, New York, pp 9–20

    Google Scholar 

  83. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD (1982) Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298: 347–350

    PubMed  CAS  Google Scholar 

  84. Valenzuela P, Quiroga M, Zaldivar J, Gray P, Rutter WJ (1980) The nucleotide sequence of the hepatitis B viral genome and the identification of the major polypeptides. In: Fields B, Jaenisch R, Fox CF (eds) Animal virus genetics. Academic Press, New York, pp 57–80

    Google Scholar 

  85. Varmus HE (1982) Form and function of retroviral proviruses. Science 216: 812–820

    PubMed  CAS  Google Scholar 

  86. Vyas GN, Blum HE (1984) Hepatitis B virus infection: Current concepts of chronicity and immunity. Western J Med 140: 754–762

    Google Scholar 

  87. Vyas GN, Dienstag JL, Hoofnagle JH (1984) Viral Hepatitis. Grune & Stratton, New York

    Google Scholar 

  88. Wain-Hobson S (1984) Molecular biology of the hepadna viruses. In: Chisari FV (ed) Advances in Hepatitis Research. Masson Publ., USA, New York, pp 49–53

    Google Scholar 

  89. Wands JR, Lieberman HM, Muchmore E, Isselbacher KJ, Shafritz DA (1982) Detection and transmission in chimpanzees of hepatitis B virus-related agents formerly designated “non-A, non-B” hepatitis. Proc Natl Acad Sci USA 79: 7552–7556

    PubMed  CAS  Google Scholar 

  90. Wang Y, Schaefer-Ridder M, Stratoma C, Wong TK, Hofschneider PH (1982) Expression of hepatitis B surface antigen in unselected cell culture transfected with recircularized HBV DNA. EMBO J 1: 1213–1216

    PubMed  CAS  Google Scholar 

  91. Weiser B, Ganem D, Seeger C, Varmus HE (1983) Closed circular viral DNA and asymmetrical heterogeneous forms in liver from animals infected with ground squirrel hepatitis virus. J Virol 48: 1–9

    PubMed  CAS  Google Scholar 

  92. Bonino F, Hoyer B, Ford E, Shih JW-K, Purcell RH, Gerin JL (1981) The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier. Hepatology 1: 127–131

    Google Scholar 

  93. Bonino F, Hoyer B, Shih JW-K, Rizzetto M, Purcell RH, Gerin JL (1984) Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect Immun 43: 1000–1005

    PubMed  CAS  Google Scholar 

  94. Govindarajan S, Kanel CC, Peters RL (1983) Prevalence of delta-antibodies among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis. Gastroenterology 85: 160–162

    PubMed  CAS  Google Scholar 

  95. Hansson BG, Moestrup T, Widell A, Nordenfelt E (1982) Infection with delta agent in Sweden: introduction of a new hepatitis agent. J Infect Dis 146: 472–478

    PubMed  CAS  Google Scholar 

  96. Ljunggren K, Patarroyo ME, Engle R, Purcell RH, Gerin JL (1984) Viral hepatitis and delta agent in Colombia. In: Vyas GN (ed) Proceedings of the 1984 international symposium on viral hepatitis. The Franklin Institute Press, Philadelphia (in press)

    Google Scholar 

  97. Lok ASF, Lindsay I, Scheuer PJ, Thomas HC (1984) Clinical and histological features of patients with chronic type B hepatitis with and without delta infection. In: Vyas GN (ed) Proceedings of the 1984 international symposium on viral hepatitis. The Franklin Institute Press, Philadelphia (in press)

    Google Scholar 

  98. Müller R, Rizzetto M, Feuerhake A, Klein H (1981) Das Delta-Antigen und sein Antikörper bei Patienten mit Lebererkrankungen. Verh Dtsch Ges Inn Med 87: 883–886

    Google Scholar 

  99. Mushahwar IK, Decker RH (1984) Prevalence of delta antigen and anti-delta detected by immunoassays in various HBsAg-positive populations. In: Vyas GN (ed) Proceedings of the 1984 international symposium on viral hepatitis. The Franklin Institute Press, Philadelphia (in press)

    Google Scholar 

  100. Ponzetto A, Forzani B, Shuja Shafi M (1984a) Delta agent infection in Saudi Arabia. A general population study. In: Vyas GN (ed) Proceedings of the 1984 international symposium on viral hepatitis. The Franklin Institute Press, Philadelphia (in press)

    Google Scholar 

  101. Ponzetto A, Purcell RH, Gerin JL (1984b) Experimental transmission of the delta agent of the eastern woodchuck (Marmota monax) In: Verme G, Bonino F, Rizzetto M (eds) Progress in clinical and biological research 143. Alan R. Liss, New York, pp 107–112

    Google Scholar 

  102. Popper H, Thung SN, Gerber MA, Hadler SC, de Monson M, Ponzetto A, Anzola E, Rivera D, Mondolfi A, Bracho A, Francis DP, Gerin JL, Maynard JE, Purcell RH (1983) Histologic studies of severe delta agent infection in Venezuelan indians. Hepatology 3: 906–912

    PubMed  CAS  Google Scholar 

  103. Purcell RH, Gerin JL, Rizzetto M, Ponzetto A, Bonino F, London WT (1984) Experimental transmission of the delta agent to chimpanzees. In: Verme G, Bonino F, Rizzetto M (eds) Progress in clinical and biological research 143. Alan R. Liss, New York, p 79

    Google Scholar 

  104. Raimondo G, Smedile A, Gallo L, Balbo A, Ponzetto A, Rizzetto M (1982) Multicenter study of prevalence of HBV-associated delta infection and liver disease in drug addicts. Lancet 1: 249–251

    PubMed  CAS  Google Scholar 

  105. Rizzetto M, Canese MG, Arico S, Crivelli O, Trepo C, Bonino F, Verme G (1977) Immunofluoresence detection of a new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in the liver and in serum of HBsAg-carriers. Gut 18: 997–1003

    PubMed  CAS  Google Scholar 

  106. Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH (1980a) Transmission of the hepatitis B virus-associated delta agent to chimpanzees. J Infect Dis 141: 590–602

    PubMed  CAS  Google Scholar 

  107. Rizzetto M, Hoyer B, Canese MG, Shih JW-K, Purcell RH, Gerin JL (1980b) Delta-agent: association of delta agent with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci USA 77: 6124–6128

    PubMed  CAS  Google Scholar 

  108. Rizzetto M, Purcell RH, Gerin JL (1980c) Epidemiology of HBV-associated delta-agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers. Lancet 1: 1215–1219

    PubMed  CAS  Google Scholar 

  109. Rizzetto M, Shih JW-K, Gerin JL (1980d) The hepatitis B virus-associated delta-antigens: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. J Immunol 125: 318–324

    PubMed  CAS  Google Scholar 

  110. Rizzetto M, Verme G, Recchia S, Bonino F, Farci P, Arico S, Calzia R, Picciotto A, Colombo M, Popper H (1983) Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 98: 437–441

    Google Scholar 

  111. Roggendorf M, Gmelin K, Zoulek G, Wolf P, Schlipköter U, Theilmann L, Deinhardt F (1984) Epidemiological studies on the prevalence of delta infections in the Federal Republic of Germany. In: Vyas GN (ed) Proceedings of the 1984 international symposium on viral hepatitis. The Franklin Institute Press, Philadelphia (in press)

    Google Scholar 

  112. Smedile A, Lavarini C, Crivelli O, Raimondo G, Fassone M, Rizzetto M (1982) Radioimmunoassay detection of IgM antibodies to the HBV-associated delta antigen: clinical significance of the delta infection. J Med Viro19: 131–138

    Google Scholar 

  113. Smedile A, Lavarini C, Farci P, Arico S, Marinucci G, Dentico P, Giuliani G, Cargnel A, Del Veccio-Blanco C, Rizzetto M (1983) Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. Am J Epidemiol 117: 223–229

    PubMed  CAS  Google Scholar 

  114. Smedile A, Rizzetto M, Bonino F, Gerin JL, Hoyer B (1984) Serum delta-associated RNA (DAR) in chronic HBV carriers infected with the delta agent. In: Vyas GN (ed) Proceedings of the 1984 international symposium on viral hepatitis. The Franklin Institute Press, Philadelphia (in press)

    Google Scholar 

  115. Stöcklin E, Gudat F, Krey G, Diirmöller U, Gasser M, Schmid M, Stalder G, Bianchi L (1981) Delta antigen in hepatitis B: immunohistology of frozen and paraffin-embedded liver biopsies and relation to HBV infection. Hepatology 1: 238

    PubMed  Google Scholar 

  116. Trepo D, Fontanges Th, Laperche P, Derose S, Trepo C (1984) Evidence for delta antigenemia in chronic HBsAg carriers in France. Association with HBeAg-CAH and usefulness for anti-delta testing. In: Vyas GN (ed) Proceedings of the 1984 international symposium on viral hepatitis. The Franklin Institute Press, Philadelphia (in press)

    Google Scholar 

  117. Alberti A, Trevisan A, Fattowich G, Realdi R (1984) The role of hepatitis B virus replication and hepatocyte membrane expression in the pathogenesis of HBV-related damage. In: Chisari FV (ed) Advances in hepatitis research. Masson Publ. Inc. USA, New York, pp 134–143

    Google Scholar 

  118. Chisari FV (1984) Hepatic immunoregulatory molecules and the pathogenesis of hepatocellular injury in viral hepatitis. In: Chisari FV (ed) Advances in hepatitis research. Masson Publ. Inc. USA, New York, pp 168–178

    Google Scholar 

  119. Dienstag JL (1984) Studies of cell-mediated immunity in chronic hepatitis B virus infection: The elusive goal of virus and host antigen specificity. In: Chisari FV (ed) Advances in hepatitis research. Masson Publ. Inc. USA, New York, pp 168–178

    Google Scholar 

  120. Mackay IR, Frazer IH (1984) Autoantibodies, autoimmunity, and chronic hepatitis. In: Chisari FV (ed) Advances in hepatitis research. Masson Publ. Inc. USA, New York, pp 179–189

    Google Scholar 

  121. Meyer zum Büschenfelde K-H, Manns M (1984) Immune response to liver membrane antigens in acute and chronic hepatitis. In: Chisari FV (ed) Advances in hepatitis research. Masson Publ. Inc. USA, New York, pp 152–162

    Google Scholar 

  122. Meyer zum Büschenfelde K-H, Manns M (1984) Mechanisms of autoimmune liver disease. In: Berk PD (ed) Seminars in liver disease, vol 4, no. 1. Thieme-Stratton Inc., New York, pp 26–35

    Google Scholar 

  123. Mondelli M, Eddleston ALWF (1984) Mechanisms of liver cell injury in acute and chronic hepatitis B. In: Berk PD (ed) Seminars in liver disease, vol 4, no. 1. Thieme-Stratton Inc., New York, pp 47–58

    Google Scholar 

  124. Mondelli M, Naumov N, Eddleston ALWF (1984) The immunopathogenesis of liver cell damage in chronic HBV infection. In: Chisari FV (ed) Advances of hepatitis research. Masson Publ. Inc., USA, New York, pp 144–151

    Google Scholar 

  125. Thomas HC, Path MRC, Lok ASF (1984) The immunopathology of autoimmune and hepatitis B virus-induced chronic hepatitis. In: Berk PD (ed) Seminars in liver disease, vol 4, no. 1. Thieme-Stratton Inc., New York, pp 36–46

    Google Scholar 

  126. Thung SN, Gerber MA (1984) Polylabumin receptors: Their role in the attachment of hepatitis B virus to hepatocytes. In: Berk PD (ed) Seminars in liver disease, vol 4, no. 1. Thieme-Stratton Inc., New York, pp 69–75

    Google Scholar 

  127. Baumgarten R, Fengler JD, Markus R, Binus R, Fischer J (1983) Zur Insulin-Glukagon-Therapie der schwer verlaufenden akuten Virushepatitis. Dtsch Gesundh-Wes 38: 913–915

    Google Scholar 

  128. Dienstag JL, Isselbacher KJ (1981) Therapy for acute and chronic hepatitis. Arch Intern Med 141: 1419–1423

    PubMed  CAS  Google Scholar 

  129. Dudley FJ, Fox RA, Sherlock S (1972) Cellular immunity and hepatitis associated, Australia antigen liver disease. Lancet 1: 723–726

    Google Scholar 

  130. Gregory PB (1981) The demise of corticosteroid therapy for acute viral hepatitis. Gastroenterology 80: 404–408

    PubMed  CAS  Google Scholar 

  131. Greenberg HB, Robinson WS, Knauer CM, Gregory PB (1981) Hepatitis B viral markers in severe viral hepatitis: Influence of steroid therapy. Hepatology 1: 54–57

    Google Scholar 

  132. Levin S, Hahn T (1982) Interferon system in acute viral hepatitis. Lancet 1: 592–594

    PubMed  CAS  Google Scholar 

  133. Lam KC, Lin HJ, Lai CL, Lam SK, Kwan YL (1978) Isoprinosine in classical acute viral hepatitis. Dig Dis 23: 893–896

    CAS  Google Scholar 

  134. Laverdant C, Molinie C, Essioux H, Daly JP (1978) A propos de la corticothérapie appliquée aux hépatites virales aigues Aleur phase initiale. Gastroenterol Clin Biol 2: 652–653

    PubMed  CAS  Google Scholar 

  135. Morrison AS, Jick H, Ory HW (1977) Oral contraceptives and hepatitis. Lancet 1: 1142–1143

    PubMed  CAS  Google Scholar 

  136. Par A, Barna K, Bajtai G, Hollos I, Ambrus M, Kovacs M, Javor T (1980) Levamisole treatment of acute viral hepatitis and HBsAg-positive chronic active hepatitis. Acta Med Acad Sci Hung 37: 269–281

    PubMed  CAS  Google Scholar 

  137. Schomerus H, Wiedmann KH, Dölle W, Peerenboom H, Strohmeyer G, Balzer K, Goebell H, Diirr HK, Bode C, Blum AL, Frösner G, Gerlich W, Berg PA, Dietz K (1984) (+)-Cyanidano1–3 in the treatment of acute viral hepatitis: A randomized controlled trial. Hepatology 4: 331–335

    Google Scholar 

  138. Czaja AJ (1984) Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis 4: 1–12

    PubMed  CAS  Google Scholar 

  139. Czaja AJ, Ludwig J, Baggenstoss AH, Wolf A (1981) Corticosteroid-treated chronic active hepatitis in remission. N Engl J Med 304: 5–9

    PubMed  CAS  Google Scholar 

  140. Czaja AJ, Davis GL, Ludwig J, Baggenstoss AH, Taswell HF (1983) Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology. Gastroenterology 85: 713–717

    PubMed  CAS  Google Scholar 

  141. Davis GL, Hoofnagle JH, Waggoner JG (1984) Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 86: 230–235

    PubMed  CAS  Google Scholar 

  142. Giusti G, Piccinino F, Galanti B, Saguelli E, Ruggiero G, Gallo C (1984) Immunsuppressive therapy in chronic active hepatitis (CAH). A multicentric retrospective study on 867 patients. Acta Hepatogastroenterol (Stuttg) 31: 24–29

    CAS  Google Scholar 

  143. De Groote J, Fevery J, Lepoutre L (1978) Long-term follow-up of chronic active hepatitis of moderate severity. Gut 19: 510–513

    PubMed  Google Scholar 

  144. Hegarty JE, Nouri Aria KT, Portmann B, Eddleston ALWF, Williams R (1983) Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatology 3: 685–689

    PubMed  CAS  Google Scholar 

  145. Hoofnagle JH, Seeff LB (1982) Natural history of chronic type B hepatitis. In: Progress in Liver Disease, pp 469–479

    Google Scholar 

  146. Nouri-Aria KT, Hegarty JE, Alexander GJM, Eddleston ALWF, Williams R (1982) Effect of corticosteroids on suppressor-cell activity in “autoimmune” and viral chronic active hepatitis. N Engl J Med 307: 1301–1304

    PubMed  CAS  Google Scholar 

  147. Kirk AP, Jain S, Pocock S, Thomas HC, Sherlock S (1980) Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. Gut 21: 78–83

    PubMed  CAS  Google Scholar 

  148. Lam KC, Lai CL, Trepo C, Wu PC (1981) Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med 304: 380–386

    PubMed  CAS  Google Scholar 

  149. Meyer zum Büschenfelde K-H (1978) Immunsuppressive Therapie der HBs-Ag-positiven und -negativen chronisch-aktiven Hepatitis. Dtsch Med Wochenschr 103: 887–892

    PubMed  CAS  Google Scholar 

  150. Schalm SW, Summerskill WHJ, Gitnick GL, Elveback LR (1976) Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis Bs-Antigen. Gut 17: 781–786

    PubMed  CAS  Google Scholar 

  151. Mackay IR (1983) Immunological aspects of chronic active hepatitis. Hepatology 3: 724–728

    PubMed  CAS  Google Scholar 

  152. Mackay IR (1984) Genetic aspects of immunologically mediated liver disease. Semin Liver Dis 4: 13–25

    PubMed  CAS  Google Scholar 

  153. Meyer zum Büschenfelde K-H, Manns M (1984) Mechanisms of autoimmune liver disease. Semin Liver Dis 4: 26–35

    Google Scholar 

  154. Miiller R, Schmidt FW (1984) HBs-Antigen-positive chronisch aggressive Hepatitis. Fortschr Med 102: 449–454

    Google Scholar 

  155. Liaw YF, Chu CM, Su IJ, Huang MJ, Lin DY, Chang-Chien CS (1983) Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis. Gastroenteorlogy 84: 216–219

    CAS  Google Scholar 

  156. Popper H, Paronetto F (1984) Problems in the immunology of hepatic diseases. Acta Hepatogastroenterol (Stuttg) 31: 1–5

    CAS  Google Scholar 

  157. Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB (1981) Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 81: 987–991

    PubMed  CAS  Google Scholar 

  158. Thomas HC, Montano L, Goodall A, De Koning R, Oladapo J, Wiedmann KH (1982) Immunological mechanisms in chronic hepatitis B virus infection. Hepatology 2: 116–121

    Google Scholar 

  159. Thomas HC, Brown D, Routhier G, Janossy G, Kung PC, Goldstein G, Sherlock S (1982) Inducer and suppressor T-cells in hepatitis B virus-induced liver disease. Hepatology 2: 202–204

    PubMed  CAS  Google Scholar 

  160. Thomas HC, Lok ASF (1984) The immunopathology of autoimmune and hepatitis B virus-induced chronic hepatitis. Semin Liver Dis 4: 36–46

    PubMed  CAS  Google Scholar 

  161. Alberti A, Realdi G, Bartolotti F, Cadrobbi P, Barbieri R, Tremolada F, Ongaro G (1981) Detection by immunofluorescence of an antigen-antibody system in patients with acute and chronic hepatitis non A, non B. Liver 1: 183–190

    PubMed  CAS  Google Scholar 

  162. Arnold W, Hess G, Porolla T (1983) Viral hepatitis an update. In: Csom6s G, Thaler H (eds) Clinical hepatology, pp 210–235

    Google Scholar 

  163. Dienes HP, Popper H, Arnold W, Lobeck H (1982) Histologic observations in human hepatitis non A, non B. Hepatology 2: 562–571

    PubMed  CAS  Google Scholar 

  164. Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV (1975) Transfusion associated hepatitis not due to viral hepatitis A or B. N Engl J Med 292: 767–770

    PubMed  CAS  Google Scholar 

  165. Barin F, Goudeau A, Denis F, Yvonnet B, Chiron JP, Coursaget P, Diop Mar I (1982) Immune response in neonates to hepatitis B vaccine. Lancet 1: 251–253

    PubMed  CAS  Google Scholar 

  166. Beasley RP, Hwang LY, Lee GCY, Lan CC, Roan CH, Huang FY, Chen CL (1983) Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2: 1099–1102

    PubMed  CAS  Google Scholar 

  167. Bommer J, Deinhardt F, Jilg W, Darai G, Andrassy K, Ritz E (1983) Impfung urämischer Patienten gegen Hepatitis B. Dtsch Med Wochenschr 48: 1823–1826

    Google Scholar 

  168. Brede HD, Deinhardt F, Eggers HJ, Haas R, Habermehl KO, Kuwert E, Maass G, Pichlmayr R, Spiess H, Stickl HA, Wolff HP (1984) AIDS und die Sicherheit des Hepatitis B Impfstoffes. Dtsch Ärztebl 81: 920–922

    Google Scholar 

  169. Deinhardt F, Deinhardt J (eds) (1983) Viral hepatitis: laboratory and clinical science. Marcel Dekker, New York, pp 1–585

    Google Scholar 

  170. Deinhardt F, Gust ID (eds) (1982) Viral hepatitis. Bull WHO 60: 661–691

    Google Scholar 

  171. Deinhardt F, Spiess H (Hrsg) (1984) Impfung gegen Hepatitis B: Erfahrungen 10 Monate nach der Zulassung und Voraussage für die Zukunft. Medizinische Verlagsgesellschaft, Marburg/Lahn (im Druck)

    Google Scholar 

  172. Deinhardt F, Weise HJ (1982) Aktive Immunprophylaxe der Hepatitis B. Bundesgesundhbl 25: 170–171

    Google Scholar 

  173. Deinhardt F, Jilg W, Zoulek G, Lorbeer B (1984) Clinical evaluation of a recombinant hepatitis B vaccine. In: Vyas GN (ed) The 1984 international symposiun on viral hepatitis. University of California, San Francisco (in press)

    Google Scholar 

  174. Dienstag JL, Watkins E, Hinkle CA (1984) Safety and immunogenicity of a recombinant hepatitis B vaccine. In: Vyas GN (ed) The 1984 international symposium on viral hepatitis. University of California, San Francisco (in press)

    Google Scholar 

  175. Dreesman GR, Sanchez Y, Ionescu-Matiu I, Sparrow JT, Six HR, Peterson DL, Hollinger FB, Melnick JL (1982) Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature 295: 158–160

    PubMed  CAS  Google Scholar 

  176. Gerety RJ (ed) Non-A, non-B hepatitis. Academic Press, New York, pp 1–301

    Google Scholar 

  177. Grady GF (1983) Prevention of hepatitis by passive immunization. In: Deinhardt F, Deinhardt J (eds) Viral hepatitis: laboratory and clinical science. Marcel Dekker, New York, pp 241–256

    Google Scholar 

  178. Ionescu-Matiu I, Kennedy RC, Sparrow JT, Culwell AR, Sanchez Y, Melnick JL, Dreesman GR (1983) Epitopes associated with a synthetic hepatitis B surface antigen peptide. J Immunol 130: 1947–1952

    PubMed  CAS  Google Scholar 

  179. Iwarson S (ed) (1983) Symposium on vaccination against hepatitis B. Scand J Infect Dis (Suppl) 38: 1–61

    Google Scholar 

  180. Jilg W, Delhoune C, Deinhardt F, Roumeliotou-Karayannis AJ, Papaevangelou GJ, Mushahwar IK, Overby LR (1984) Hepatitis surface antigen ( HBsAg) subtype-specific antibodies in persons vaccinated against hepatitis B. J Med Virol 13: 171–178

    Google Scholar 

  181. Kennedy RC, Dreesman GR, Sparrow JT, Culwell AR, Sanchez Y, Ionescu-Matiu I, Hollinger FB, Melnick JL (1983) Inhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptide. J Viro146: 653–655

    Google Scholar 

  182. Lee GCY, Hwang LY, Beasley RP, Chen SH, Lee TY (1983) Immunogenicity of hepatitis B virus vaccine in healthy Chinese neonates. J Infect Dis 148: 526–529

    PubMed  CAS  Google Scholar 

  183. Lerner RA (1983) Synthetic vaccines. Scientific American 248: 48–56

    Google Scholar 

  184. Lerner RA, Green N, Alexander H, Liu FT, Sutcliffe JG, Shinnick TM (1981) Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci USA 78: 3403–3407

    PubMed  CAS  Google Scholar 

  185. McAleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ, Hilleman MR (1984) Human hepatitis B vaccine from recombinant yeast. Nature 307: 178–180

    PubMed  CAS  Google Scholar 

  186. Müller R, Arnold W, Deinhardt F, Feuerhake A, Grob PJ, Lauchart W (1984) In: Deinhardt F, Spiess H (Hrsg) Impfung gegen Hepatitis B: Erfahrungen 10 Monate nach der Zulassung und Voraussage für die Zukunft. Medizinische Verlagsgesellschaft mbH, Marburg/Lahn (im Druck)

    Google Scholar 

  187. Neurath AR, Kent SBH, Strick N (1982) Specificity of antibodies elicited by a synthetic peptide having a sequence in common with a fragment of a virus protein, the hepatitis B surface antigen. Proc Natl Acad Sci USA 79: 7871–7875

    PubMed  CAS  Google Scholar 

  188. Prince AM, Ikram H, Hopp TP (1982) Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide. Proc Natl Acad Sci USA 79: 579–582

    PubMed  CAS  Google Scholar 

  189. Procesky OW, Stevens CE, Szmuness W, Rolka H, Harley EJ, Kew MC, Scholtz JER, Mitchell AD (1983) Immune response to hepatitis B vaccine in newborns. J Infect (Suppl 1 ) 7: 53–55

    Google Scholar 

  190. Provost PJ, Conti PA, Giesa PA, Banker FS, Buynak EB, McAleer WJ, Hilleman MR (1983) Studies in chimpanzees of live, attenuated hepatitis A vaccine candidates (41570). Proc Soc Exp Biol Med 172: 357–363

    PubMed  CAS  Google Scholar 

  191. Rosendahl C, Deinhardt F, Tichmann I, Bauer CP (1984) Hepatitis B-Schutzimpfung (passiv-aktiv) von Neugeborenen. In: Deinhardt F, Spiess H (Hrsg) Impfung gegen Hepatitis B: Erfahrungen 10 Monate nach der Zulassung von Voraussage für die Zukunft. Medizinische Verlagsgesellschaft mbH, Marburg/Lahn (im Druck)

    Google Scholar 

  192. Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter HJ, Taylor PE, de Vera A, Chen GTS, Kellner A, and the dialysis vaccine trial study group (1982) Hepatitis B vaccine in medical staff of hemodialysis units. N Engl J Med 307: 1481–1486

    Google Scholar 

  193. Ticehurst JR, Racaniello VR, Baröudy BM, Baltimore D, Purcell RH, Feinstone SM (1983) Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci USA 80: 5885–5889

    PubMed  CAS  Google Scholar 

  194. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD (1982) Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298: 347–350

    PubMed  CAS  Google Scholar 

  195. von der Helm K, Deinhardt F (1983) Cloning and expression of hepatitis A virus DNA in prokaryotic cells. In: Chisari F (ed) Advances in hepatitis research. Masson Publ., New York, pp 263–267

    Google Scholar 

  196. von der Helm K, Winnacker EL, Deinhardt F, Frösner GG, Gauss-Müller V, Bayerl B, Scheid R, Siegl G (1981) Cloning of hepatitis A virus genome. J Virol Methods 3: 37–43

    PubMed  Google Scholar 

  197. Welsby PD, Roylance PJ (eds) (1983) Worldwide control of hepatitis B. J Infect (Suppl 1 ) 7: 1–107

    Google Scholar 

  198. WHO (1983a) Acquired immune deficiency syndrome (AIDS). WHO Wkly Epidem Rec 58: 369–370

    Google Scholar 

  199. WHO (1983b) Viral hepatitis, the use of normal and specific immunoglobufin. WHO Wkly Epidem Rec 58: 237

    Google Scholar 

  200. Young P, Vaudin M, Dixon J, Zuckerman Al (1982) Preparation of hepatitis B polypeptide micelles from human carrier plasma. J Virol Methods 4: 177–185

    PubMed  CAS  Google Scholar 

  201. Zachoval R, Jilg W, Lorbeer B, Schmidt M, Deinhardt F (1984) Passive-active immunization against hepatitis B. J Infect Dis (in press)

    Google Scholar 

  202. Zoulek G, Jilg W, Deinhardt F (1983) Immunprophylaxe der Hepatitis B. Dtsch Med Wochenschr 108: 1135–1136, 1175–1177, 1223–1229, 1263–1268

    Google Scholar 

  203. Widmer UK, Villaverde A, Grob PJ (1980) Hepatitisepidemiologie 1977 bis 1979. Schweiz Med Wochenschr 110: 930–937

    PubMed  CAS  Google Scholar 

  204. Grob PJ, Rickenbach M, Wagner S, Steffen R, Gutzwiller F (1983) Hepatitis B vaccination of high-risk individuals in the Canton of Zurich. Eur J Clin Microbiol 2: 309–315

    PubMed  CAS  Google Scholar 

  205. Grob PJ, Binswanger U, Zaruba K, Joller-Jemelka HJ et al. (1983) Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipients. Antiviral Res 3: 43–52

    PubMed  CAS  Google Scholar 

  206. Alexander JJ, Bey EM, Geddes EW et al. (1976) Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J 50: 2124

    PubMed  CAS  Google Scholar 

  207. Bassendine MF, Della Seta L, Salmeroon J, Thomas HC, Sherlock S (1983) Incidence of hepatitis B virus infection in alcoholic liver disease, HBsAg negative chronic active liver disease and primary liver cell cancer in Britain. Liver 3: 65

    Google Scholar 

  208. Beasley RP (1982) Hepatitis B virus as the etiologic agent in hepatocellular carcinoma —epidemiologic considerations. Hepatology 2: 21S

    Google Scholar 

  209. Bréchot Ch, Pourcel Ch, Hadchouel M, Dejean A, Louise A, Scotto J, Tiollais P (1982) State of hepatitis B virus DNA in liver diseases. Hepatology 2: 27S

    Google Scholar 

  210. Bréchot Ch, Nalpas B, Couroucé AM, Duhamel G, Callard P, Carnot F, Tiollais P, Berthelot P (1982) Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. N Engl J Med 306: 1384

    PubMed  Google Scholar 

  211. Butler R, Frei PC, Frey-Wettstein M, Grob PJ, Krech U, Lambert PH (1974) Evaluation eines Radioimmunoassays fur Reihenuntersuchungen auf Hepatitis-B-Antigen bei Blutspendern. Schweiz Med Wochenschr 104: 1316

    PubMed  CAS  Google Scholar 

  212. Chen DS, Hoyer BH, Nelson J, Purcell RH, Gerin JL (1982) Detection and properties of hepatitis B viral DNA in liver tissues from patients with hepatocellular carcinoma. Hepatology 2: 42S

    Google Scholar 

  213. Chu CM, Liaw Y-F, Sheen I-S, Lin D-Y, Huang M-J (1983) Sex difference in chronic hepatitis B virus infection: An appraisal based on the status of hepatitis Be antigen and antibody. Hepatology 3: 947

    Google Scholar 

  214. Davis GL, Hoofnagle JH, Waggoner JG (1984) Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 86: 230

    PubMed  CAS  Google Scholar 

  215. Denison EK, Peter RL, Reynolds TB (1971) Familial hepatoma with hepatitis associated antigen. Ann Intern Med 74: 391

    PubMed  CAS  Google Scholar 

  216. Frey P, Schmid M, Knoblauch M (1975) Die Klinik des Leberkarzinoms. Dtsch Med Wochenschr 100: 1625

    PubMed  CAS  Google Scholar 

  217. Groopman JE (1983) Viruses and human neoplasia. Approaching etiology. Am J Med 75: 377

    PubMed  CAS  Google Scholar 

  218. Gudat F, Bianchi L, Stalder GA, Schmid M (1976) Klassifizierung and Infektiosität der chronischen Hepatitis B, definiert durch Dane-Partikel im Blut and Virus-Komponenten in der Leber. Schweiz Med Wochenschr 106: 812

    PubMed  CAS  Google Scholar 

  219. Hadziyannis SJ (1980) Hepatocellular carcinoma and type B hepatitis. Clin Gastroenterol 9: 117–15. Hadziyannis SJ, Lieberman HM, Karvountzis GG, Shafritz DA (1983) Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg vs anti-HBe positive carriers of hepatitis B virus. Hepatology 3: 656

    Google Scholar 

  220. Hus H-C, Lin W-S-J, Tasi M-J (1983) Hepatitis B surface antigen and hepatocellular carcinoma in Taiwan. Cancer 52: 1825

    Google Scholar 

  221. Kew MC (1983) Hepatocellular carcinoma. Postgrad Med J (Suppl 4 ) 59: 78

    Google Scholar 

  222. Lai CL, Wu PC, Lam KC, Todd D (1979) Histologic prognostic indicators in hepatocellular carcinoma. Cancer 44: 1677

    PubMed  CAS  Google Scholar 

  223. London W-T (1981) Primary hepatocellular carcinoma - etiology, pathogenesis, and prevention. Hum Pathol 12: 1085

    PubMed  CAS  Google Scholar 

  224. London T, Blumberg BS (1982) A cellular model of the role of hepatitis B virus in the pathogenesis of primary hepatocellular carcinoma. Hepatology 2: 10S

    Google Scholar 

  225. Marion PL, Knight SS, Salazar FH, Popper H, Robinson WS (1983) Ground squirrel hepatitis virus infection. Hepatology 3: 519

    PubMed  CAS  Google Scholar 

  226. Mitamura K, Hoyer BH, Ponzetto A, Nelson J, Purcell RH, Gerin JL (1982) Woodchuck hepatitis virus DNA in Woodchuck liver tissues. Hepatology 2: 47S

    Google Scholar 

  227. Nayak NC, Dhar A, Sachdeva R et al. (1977) Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver. Int J Cancer 20: 643

    PubMed  CAS  Google Scholar 

  228. Nazarewicz T, Krawczynski K, Slusarczyk J et al. (1977) Cellular localization of hepatitis B virus antigen in patients with hepatocellular carcinoma coexisting with liver cirrhosis. J Infect Dis 135: 298

    PubMed  CAS  Google Scholar 

  229. Obata H, Hatashi N, Motoike Y et al. (1980) A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection. Int J Cancer 25: 741

    PubMed  CAS  Google Scholar 

  230. Okuda K, Nakashima T, Sakamoto K, Ikari T, Hidaka H, Kubo Y, Sakuma K, Motoike Y, Okuda H, Obata H (1982) Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers. Cancer 49: 450

    PubMed  CAS  Google Scholar 

  231. Peters RL, Afroudakis AP, Tatler D (1977) The changing incidence of association of hepatitis B with hepatocellular carcinoma in California. Am J Clin Pathol 68: 1

    PubMed  CAS  Google Scholar 

  232. Pirovino M, Heer M, Joller HP, Altorfer J, Akovbiantz A, Schmid M (1983) Hepatocellular carcinoma and hepatitis B virus infection. Analysis of 75 cases from Switzerland. Liver 3: 398

    PubMed  CAS  Google Scholar 

  233. Popper H, Shih J W-K, Gerin JL et al. (1981) Woodchuck hepatitis and hepatocellular carcinoma: correlation of histologic with virologic observations. Hepatology 1: 91

    PubMed  CAS  Google Scholar 

  234. Popper H, Gerber MA, Thung SN (1982) The relation of hepatocellular carcinoma to infection with hepatitis B and related to viruses in man and animals. Hepatology 2: 1S

    Google Scholar 

  235. Prince AM, Alcabes P (1982) The risk of development of hepatocellular carcinoma in hepatitis B virus carriers in New York. A preliminary estimate using death-records matching. Hepatology 2: 15S

    Google Scholar 

  236. Prince AM, Szmuness W, Michon J et al. (1975) A case control study of the association between primary liver cancer and hepatitis B infection in Senegal. Int J Cancer 16: 376

    PubMed  CAS  Google Scholar 

  237. Resnick RH, Stone K, Antonioli D (1983) Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis. Am J Dig Dis 28: 908

    CAS  Google Scholar 

  238. Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC (1981) Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N Engl. J Med. 305: 1067

    Google Scholar 

  239. Shafritz DA (1982) Hepatitis B virus DNA molecules in the liver of HBsAg carriers: Mechanistic considerations in the pathogenesis of hepatocellular carcinoma. Hepatology 2: 35S

    Google Scholar 

  240. Shafritz DA, Shouval D, Hern MA (1982) Recombinant DNA and the liver: studies with albumin, alpha-fetoprotein, hepatitis B virus and other DNA probes. In: Popper H, Schaffner F (eds) Progress in liver diseases, vol V II

    Google Scholar 

  241. Sherlock S (ed) (1983) Hepatitis B virus infection: The impact of molecular biology. Hepatology 3: 455

    Google Scholar 

  242. Stromeyer FW, Ishak KG, Gerber MA, Mathwe T (1980) Ground-glass cells in hepatocellular carcinoma. Am J Clin Pathol 74: 254

    PubMed  CAS  Google Scholar 

  243. Summers J, Smolec JM, Snyder R (1978) A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in Woodchucks. Proc Natl Acad Sci USA 75: 4533

    PubMed  CAS  Google Scholar 

  244. Summers J, Mason WS (1982) Properties of the hepatitis B-like viruses related to their taxonomic classification. Hepatology 2: 61S

    Google Scholar 

  245. Tan AYO, Law CH, Lee YS (1977) Hepatitis B antigen in the liver cells in cirrhosis and hepatocellular carcinoma. Pathology 9: 57

    PubMed  CAS  Google Scholar 

  246. Tao LC, Ho CS, McLouglin MJ, Evans WK, Donat EE (1984) Cytologic diagnosis of hepatocellular carcinoma by fine-needle aspiration biopsy. Cancer 53: 547

    PubMed  CAS  Google Scholar 

  247. Topp WC, Hightower MJ, Ramundo MB, Smith DM, Anderson MA (1982) Common features of transformation and tumor induction by DNA viruses. Hepatology 2: 51S

    Google Scholar 

  248. Turbitt ML, Patrick RS, Goudie RB et al. (1977) Incidence in southwest Scotland of hepatitis B surface antigen in the liver of patients with hepatocellular carcinoma. J Clin Pathol 30: 1124

    PubMed  CAS  Google Scholar 

  249. Waterhouse JAH, Muir C, Correa P et al. (1977) Cancer incidence in five continents, vol 3. International Agency for Research on Cancer, Lyons

    Google Scholar 

  250. Wellmann KF, Gerstmann KE (1979) Virushepatitis-Infektion and Leberkarzinom. Dtsch Med Wochenschr 104: 927

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Marburg, Deutschland

    G. A. Martini

  2. Department of Laboratory Medicine and Liver Center, University of California, San Francisco, USA

    H. E. Blum & G. N. Vyas

  3. 3Max-von-Pettenkofer-Institut für Hygiene, Med. Mikrobiologie, München, Deutschland

    M. Roggendorf

  4. I. Medizinische Klinik und Poliklinik, Johannes-Gutenberg-Universität, Mainz, USA

    K.-H. Meyer. zum Büschenfelde

  5. Fachbereich Gastroenterologie der Medizinischen Klinik Eßlingen, Akademisches Lehrkrankenhaus der Universität Tübingen, Deutschland

    K. P. Maier

  6. Medizinische Klinik und Poliklinik D, Universität Düsseldorf, Deutschland

    G. Strohmeyer & H.-J. Lübke

  7. Klinik für Innere Medizin II, Kliniken der Freien Hansestadt Bremen, Zentralkrankenhaus, St.-Jürgen-Straße, Deutschland

    W. Arnold

  8. Max-von-Pettenkofer-Institut für Hygiene, Med. Mikrobiologie, München, Deutschland

    F. Deinhardt

  9. Abteilung für Klinische Immunologie, Departement für Innere Medizin, Universitätsspital Zürich, Schweiz

    P. J. Grob, R. Steffen & M. Rickenbach

  10. Institut für Sozial-und Präventivmedizin, Universität Zürich, Schweiz

    P. J. Grob, R. Steffen & M. Rickenbach

  11. Stadtspital Waid, Zürich, Schweiz

    M. Schmid

Authors
  1. G. A. Martini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. E. Blum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. N. Vyas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Roggendorf
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K.-H. Meyer. zum Büschenfelde
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. P. Maier
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Strohmeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H.-J. Lübke
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. W. Arnold
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. F. Deinhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. P. J. Grob
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. R. Steffen
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. M. Rickenbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. M. Schmid
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Martini, G.A. et al. (1984). Die Vielgestaltigkeit der Virushepatitis. In: 90. Kongreß. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 90. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-85457-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85457-6_6

  • Publisher Name: J.F. Bergmann-Verlag, Munich

  • Print ISBN: 978-3-8070-0342-9

  • Online ISBN: 978-3-642-85457-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation